Zoetis Inc. (NYSE: ZTS) sees major insider selling with its EVP offloading 652 stock shares. Despite this, ZTS has witnessed an 8.1% increase since its last earnings report. With multiple investment firms, such as
Stokes Capital Advisors and
Portside Wealth Group, increasing their stake in the company, ZTS's stock has risen by 13% within a span of a month. The global animal health company recently released its
2024 sustainability progress update. Share purchases by multiple trusts like
Blue Zone Wealth Advisors and
Merit Financial Group have also boosted its position. However, questions remain over the stock's performance in the S&P 500, triggering a mixed market response. On the other hand, Zoetis's Q1 earnings report showcased a notable increase in shares owned by several companies, including
Sarasin & Partners and
Fairtree Asset Management. Builds momentum despite
competitive pressures, and is touted as a top momentum stock for the long term. However, the analyst firm Zacks Research has shown a negative outlook for ZTS's Q2 earnings.
Zoetis ZTS News Analytics from Mon, 30 Dec 2024 08:00:00 GMT to Sat, 07 Jun 2025 14:54:26 GMT -
Rating 5
- Innovation 0
- Information 8
- Rumor -4
